SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-027157
Filing Date
2022-05-16
Accepted
2022-05-16 16:32:03
Documents
91
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_abvcbio.htm   iXBRL 10-Q 1141160
2 AMENDMENT TO THE COLLABORATION AGREEMENT DATED DECEMBER 29, 2015 f10q0322ex10-22_abvcbio.htm EX-10.22 8365
3 CERTIFICATION f10q0322ex31-1_abvcbio.htm EX-31.1 13431
4 CERTIFICATION f10q0322ex31-2_abvcbio.htm EX-31.2 13283
5 CERTIFICATION f10q0322ex32-1_abvcbio.htm EX-32.1 4743
6 CERTIFICATION f10q0322ex32-2_abvcbio.htm EX-32.2 4432
  Complete submission text file 0001213900-22-027157.txt   7191905

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE abvc-20220331.xsd EX-101.SCH 98042
8 XBRL CALCULATION FILE abvc-20220331_cal.xml EX-101.CAL 37739
9 XBRL DEFINITION FILE abvc-20220331_def.xml EX-101.DEF 356910
10 XBRL LABEL FILE abvc-20220331_lab.xml EX-101.LAB 686590
11 XBRL PRESENTATION FILE abvc-20220331_pre.xml EX-101.PRE 372150
85 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_abvcbio_htm.xml XML 851063
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 22929824
SIC: 2834 Pharmaceutical Preparations